Partner Content Partner Content Wilmington Healthcare wins first client for new NHS transfor... Product helps pharma identify opportunities and tailor
Views & Analysis The changing frontline: how to engage with England’s NHS in ... Wilmington Healthcare-pharmaphorum conference: England’s NHS is moving towards integrated care, and long-term outcomes-based contracts for medicines could become the norm
Views & Analysis The NHS, new models of care and STPs: what role for pharma? These are challenging times in the NHS, with reforms and budget restrictions putting the health service under huge strain.
Views & Analysis How can pharma help NHS improve mental health services? Sustainability and Transformation Plans present an opportunity for pharma to support research into mental health conditions.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
